[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216731-gvntTpPLbbpIuRmiGail",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\",\n  \"answer_letter\": \"D\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Assessing Surveillance Strategies**\n\nI'm currently evaluating the optimal post-procedure surveillance program for a patient following superficial femoral artery stenting. I'm carefully considering the various answer options and comparing them with established medical standards. I'm focusing on balancing efficacy and practicality.\n\n\n**Considering Surveillance Modalities**\n\nMy analysis continues, now focusing on the tools themselves. I'm delving into the specifics, weighing the pros and cons of each modality. Duplex ultrasound is looking like a frontrunner, given its detailed anatomical and hemodynamic data. I'm still figuring out the ideal timing intervals for follow-ups, though.\n\n\n**Defining the Surveillance Protocol**\n\nMy attention is now on the answer choices. I'm focusing on the specifics of each proposed surveillance plan, specifically considering what is included and excluded. Currently, I'm leaning towards the options that include duplex ultrasound. The timing of follow-up is also important, and I'm assessing how well each option aligns with best practices for detection of restenosis after SFA stenting.\n\n\n**Assessing Answer Options**\n\nI'm now comparing each option's surveillance plan to established guidelines. A and C's omission of duplex ultrasound is a significant drawback. B and D both include duplex, making them more attractive. I'm carefully comparing the timing intervals of B and D to identify the best balance of thoroughness and practicality for this patient.\n\n\n**Synthesizing Optimal Surveillance Plan**\n\nI'm now refining my assessment. Considering the patient's presentation and the provided options, I'm focusing on the frequency and timing of follow-up evaluations. The inclusion of duplex ultrasound is a clear requirement, so I'm honing in on the details of B and D to determine which best fits.\n\n\n**Determining Best Surveillance Choice**\n\nI'm now zeroing in on the nuances of B and D. While both incorporate arterial duplex, the timing differences are notable. Guidelines from ACC/AHA and SVS influence my decision-making. D's longer follow-up provides a slight edge, but B's earlier assessment is also appealing. I'm focusing on the ideal balance of early detection and long-term monitoring.\n\n\n**Identifying Optimal Choice**\n\nI'm now weighing the finer points of B and D again. Both offer duplex, which is crucial. D's extended surveillance to two years is attractive. While B's earlier start at one month provides a key initial check, the long-term approach of D aligns better with surveillance recommendations.\n\n\n**Comparing Surveillance Plans**\n\nI'm now comparing the choices, zeroing in on B and D. While B's initial month-one visit is appealing, D's inclusion of a two-year follow-up and focus on the important intervals is compelling. I'm focusing on the established guidelines and common practice recommendations from various societies to confirm my choice.\n\n\n**Prioritizing the Optimal Approach**\n\nI'm now focusing on refining the choice. Despite initial inclinations towards D, I'm carefully reviewing the merits of B's early duplex and the extended surveillance of D. Guidelines favor duplex inclusion, but timing nuances are key. The patient's long-term well-being is my ultimate aim.\n\n\n**Comparing Restenosis Risks**\n\nNow I'm delving deeper, weighing the specific risks and benefits of each surveillance timing schedule. I am focusing on the likelihood of restenosis within specific intervals. I'm aiming for a balance between early detection and avoiding unnecessary follow-ups.\n\n\n**Revising Surveillance Strategy**\n\nI'm now reconsidering the options, focusing on the timing intervals of the duplex ultrasound. Option D, with its 3, 6, 12-month and 2-year approach, appears more robust. It is important to confirm what is considered standard and most appropriate.\n\n\n**Prioritizing Timing Intervals**\n\nI'm now zeroing in on the importance of those intervals. The ideal plan must balance early detection with efficient follow-up. While B's earlier check is attractive, D's focus on the 6-month and 2-year marks gives it the edge.\n\n\n**Finalizing Surveillance Recommendation**\n\nI'm now completely settled on the most suitable choice, which is option D. While B offered an early check, D's inclusion of the six-month assessment and two-year follow-up period aligns perfectly with recommended surveillance protocols, providing a robust approach for monitoring the patient's long-term vascular health.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Assessing Surveillance Strategies**\n\nI'm currently evaluating the optimal post-procedure surveillance program for a patient following superficial femoral artery stenting. I'm carefully considering the various answer options and comparing them with established medical standards. I'm focusing on balancing efficacy and practicality.\n\n\n**Considering Surveillance Modalities**\n\nMy analysis continues, now focusing on the tools themselves. I'm delving into the specifics, weighing the pros and cons of each modality. Duplex ultrasound is looking like a frontrunner, given its detailed anatomical and hemodynamic data. I'm still figuring out the ideal timing intervals for follow-ups, though.\n\n\n**Defining the Surveillance Protocol**\n\nMy attention is now on the answer choices. I'm focusing on the specifics of each proposed surveillance plan, specifically considering what is included and excluded. Currently, I'm leaning towards the options that include duplex ultrasound. The timing of follow-up is also important, and I'm assessing how well each option aligns with best practices for detection of restenosis after SFA stenting.\n\n\n**Assessing Answer Options**\n\nI'm now comparing each option's surveillance plan to established guidelines. A and C's omission of duplex ultrasound is a significant drawback. B and D both include duplex, making them more attractive. I'm carefully comparing the timing intervals of B and D to identify the best balance of thoroughness and practicality for this patient.\n\n\n**Synthesizing Optimal Surveillance Plan**\n\nI'm now refining my assessment. Considering the patient's presentation and the provided options, I'm focusing on the frequency and timing of follow-up evaluations. The inclusion of duplex ultrasound is a clear requirement, so I'm honing in on the details of B and D to determine which best fits.\n\n\n**Determining Best Surveillance Choice**\n\nI'm now zeroing in on the nuances of B and D. While both incorporate arterial duplex, the timing differences are notable. Guidelines from ACC/AHA and SVS influence my decision-making. D's longer follow-up provides a slight edge, but B's earlier assessment is also appealing. I'm focusing on the ideal balance of early detection and long-term monitoring.\n\n\n**Identifying Optimal Choice**\n\nI'm now weighing the finer points of B and D again. Both offer duplex, which is crucial. D's extended surveillance to two years is attractive. While B's earlier start at one month provides a key initial check, the long-term approach of D aligns better with surveillance recommendations.\n\n\n**Comparing Surveillance Plans**\n\nI'm now comparing the choices, zeroing in on B and D. While B's initial month-one visit is appealing, D's inclusion of a two-year follow-up and focus on the important intervals is compelling. I'm focusing on the established guidelines and common practice recommendations from various societies to confirm my choice.\n\n\n**Prioritizing the Optimal Approach**\n\nI'm now focusing on refining the choice. Despite initial inclinations towards D, I'm carefully reviewing the merits of B's early duplex and the extended surveillance of D. Guidelines favor duplex inclusion, but timing nuances are key. The patient's long-term well-being is my ultimate aim.\n\n\n**Comparing Restenosis Risks**\n\nNow I'm delving deeper, weighing the specific risks and benefits of each surveillance timing schedule. I am focusing on the likelihood of restenosis within specific intervals. I'm aiming for a balance between early detection and avoiding unnecessary follow-ups.\n\n\n**Revising Surveillance Strategy**\n\nI'm now reconsidering the options, focusing on the timing intervals of the duplex ultrasound. Option D, with its 3, 6, 12-month and 2-year approach, appears more robust. It is important to confirm what is considered standard and most appropriate.\n\n\n**Prioritizing Timing Intervals**\n\nI'm now zeroing in on the importance of those intervals. The ideal plan must balance early detection with efficient follow-up. While B's earlier check is attractive, D's focus on the 6-month and 2-year marks gives it the edge.\n\n\n**Finalizing Surveillance Recommendation**\n\nI'm now completely settled on the most suitable choice, which is option D. While B offered an early check, D's inclusion of the six-month assessment and two-year follow-up period aligns perfectly with recommended surveillance protocols, providing a robust approach for monitoring the patient's long-term vascular health.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216731,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 3424,
        "prompt_tokens": 299,
        "total_tokens": 3723,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 3370,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.008563203,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.97e-05,
          "upstream_inference_completions_cost": 0.00856
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216731-MuHa7y5xemyRR6YQ7QuR",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\",\n  \"answer_letter\": \"D\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Assessing Surveillance Strategies**\n\nI'm currently grappling with the nuances of post-angioplasty and stenting surveillance for SFA stenosis. The core challenge involves selecting the optimal monitoring program for this specific patient. I'm focusing on balancing efficacy, patient risk, and resource utilization to refine my recommendations.\n\n\n**Prioritizing Surveillance Protocols**\n\nNow, I'm analyzing the post-procedure surveillance options in greater detail. I'm leaning heavily towards the necessity of duplex ultrasound, especially considering the high restenosis rates in the superficial femoral artery. Also, I'm working on defining a reasonable timeline for monitoring frequency based on standard practice guidelines. I'm looking at clinical assessment and ABI, but leaning on duplex ultrasound's ability to identify restenosis as crucial.\n\n\n**Deciding Surveillance Details**\n\nI'm now comparing surveillance protocols, specifically A through D. I'm focusing on their key elements and timing. Option B seems most promising given its inclusion of duplex ultrasound at 1, 3, and 12 months. However, I am still comparing it to Option D, which also incorporates duplex but at slightly different intervals. I'm considering the pros and cons of each option's frequency and the importance of duplex.\n\n\n**Refining Surveillance Criteria**\n\nI'm now carefully evaluating the pros and cons of each surveillance option, weighing the evidence. The critical factor is identifying which plan balances early restenosis detection with practicality. I'm focusing on the strengths and weaknesses of each option, with a particular emphasis on the role of duplex ultrasound, especially within the first year.\n\n\n**Synthesizing Surveillance Options**\n\nI'm now carefully analyzing the different surveillance programs. I'm focusing on the necessity of including both duplex ultrasound and regular clinical assessment. I have weighed each option and its timing to maximize the detection of restenosis and minimize the risk. Ultimately, I am looking to establish an ideal surveillance protocol.\n\n\n**Selecting the Optimal Protocol**\n\nI'm now fully comparing the given options. I've considered the significance of duplex ultrasound, especially within the first year after the procedure. I've concluded that Option D best aligns with established guidelines for post-SFA stenting surveillance, given its frequency and comprehensive nature.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Assessing Surveillance Strategies**\n\nI'm currently grappling with the nuances of post-angioplasty and stenting surveillance for SFA stenosis. The core challenge involves selecting the optimal monitoring program for this specific patient. I'm focusing on balancing efficacy, patient risk, and resource utilization to refine my recommendations.\n\n\n**Prioritizing Surveillance Protocols**\n\nNow, I'm analyzing the post-procedure surveillance options in greater detail. I'm leaning heavily towards the necessity of duplex ultrasound, especially considering the high restenosis rates in the superficial femoral artery. Also, I'm working on defining a reasonable timeline for monitoring frequency based on standard practice guidelines. I'm looking at clinical assessment and ABI, but leaning on duplex ultrasound's ability to identify restenosis as crucial.\n\n\n**Deciding Surveillance Details**\n\nI'm now comparing surveillance protocols, specifically A through D. I'm focusing on their key elements and timing. Option B seems most promising given its inclusion of duplex ultrasound at 1, 3, and 12 months. However, I am still comparing it to Option D, which also incorporates duplex but at slightly different intervals. I'm considering the pros and cons of each option's frequency and the importance of duplex.\n\n\n**Refining Surveillance Criteria**\n\nI'm now carefully evaluating the pros and cons of each surveillance option, weighing the evidence. The critical factor is identifying which plan balances early restenosis detection with practicality. I'm focusing on the strengths and weaknesses of each option, with a particular emphasis on the role of duplex ultrasound, especially within the first year.\n\n\n**Synthesizing Surveillance Options**\n\nI'm now carefully analyzing the different surveillance programs. I'm focusing on the necessity of including both duplex ultrasound and regular clinical assessment. I have weighed each option and its timing to maximize the detection of restenosis and minimize the risk. Ultimately, I am looking to establish an ideal surveillance protocol.\n\n\n**Selecting the Optimal Protocol**\n\nI'm now fully comparing the given options. I've considered the significance of duplex ultrasound, especially within the first year after the procedure. I've concluded that Option D best aligns with established guidelines for post-SFA stenting surveillance, given its frequency and comprehensive nature.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216732,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1380,
        "prompt_tokens": 299,
        "total_tokens": 1679,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1326,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.003504303,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.97e-05,
          "upstream_inference_completions_cost": 0.00345
        }
      },
      "provider": "Google"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "google/gemini-2.5-flash",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning": {
        "max_tokens": 8192
      },
      "reasoning_effort": null,
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762216731-3HS1FLtfKy7HJepYIUde",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\n  \"answer\": \"Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\",\n  \"answer_letter\": \"D\"\n}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Assessing Surveillance Strategies**\n\nI'm currently reviewing various post-procedure surveillance options for SFA stenting. My focus is now on the established medical guidelines and best practices for follow-up care in these cases, to determine which program offers the most appropriate level of monitoring. I need to balance the need for early detection of complications against the invasiveness and cost of the surveillance methods.\n\n\n**Defining Optimal Surveillance Protocols**\n\nI'm now prioritizing the need for duplex ultrasound in any adequate surveillance program for SFA stenting. My evaluation hinges on comparing the options to standard guidelines for post-procedure care. While clinical assessment and ABI measurement are baseline requirements, the absence of duplex ultrasound, the primary imaging method to detect stent issues, is a critical shortcoming.\n\n\n**Comparing Surveillance Options**\n\nI'm now comparing and contrasting the proposed surveillance protocols in detail. I'm focusing on the necessity of duplex ultrasound, a crucial imaging modality. I'm noting the strengths and weaknesses of each option relative to standard guidelines. The frequency of imaging, specifically the presence and timing of duplex ultrasound, is the most crucial differentiator in evaluating the options.\n\n\n**Refining Protocol Recommendations**\n\nI'm now prioritizing the combination of clinical assessment, ABI measurement, and duplex ultrasound. Reviewing all options, I've concluded that regular duplex scans, even without explicit mention of ABI, are of greater value for SFA stenting surveillance. I'm focusing on the timing of these assessments, as frequent monitoring is crucial during the first year or two post-procedure. The optimal protocol balances clinical insights, physiological measurements, and, most critically, the utilization of duplex ultrasound imaging.\n\n\n**Determining the Ideal Choice**\n\nI'm now prioritizing the optimal combination of assessment modalities and their frequency for post-SFA stenting surveillance. Considering standard medical guidelines, I'm finding that options including duplex ultrasound, such as option B and D, are superior due to the imaging modality's diagnostic capabilities. Option D seems superior, providing extended surveillance to two years. While I prefer an option including both ABI and duplex, in a forced choice, duplex is more crucial for detecting stent-specific complications.\n\n\n**Choosing the Optimal Post-Procedure Plan**\n\nI'm now prioritizing the factors that inform my choice. Given the choices, and focusing on guidelines, I've concluded option D provides the most appropriate frequency for duplex ultrasound, essential for detecting issues in the stent. The 2-year surveillance period is also advantageous. While ABI is also important, and commonly done with duplex, duplex itself is more crucial for post-stenting imaging.\n\n\n**Choosing the Optimal Post-Procedure Plan**\n\nGiven the provided choices, I'm now comparing the merits of each post-operative plan. Option D, offering duplex ultrasound at 3, 6, 12 months, and 2 years, appears superior. It offers critical imaging, although not explicitly including ABI, the duplex ultrasound schedule aligns with standard surveillance guidelines, and the longer surveillance period is preferable.\n\n\n**Final Recommendation Refinement**\n\nConsidering all the presented choices and guidelines, I'm now leaning towards option D as the most effective surveillance strategy. It provides regular duplex ultrasound imaging, considered crucial for stent integrity assessment, and offers the best frequency. The 2-year surveillance aligns with the increased risk of late-stage complications, specifically relating to SFA stenting. While the absence of explicit ABI mention is a mild concern, the duplex schedule, combined with vascular assessment, makes it the superior choice.\n\n\n**Final Protocol Selection**\n\nI'm now focusing on SFA stenting. My choice has become clear: Option D is the most suitable, given my analysis and the guidelines. The critical factor is the inclusion of duplex ultrasound at frequent, strategic intervals, particularly during the first two years. Although ABI is vital, the duplex ultrasound schedule, coupled with routine vascular assessment, makes it the superior choice.\n\n\n**Finalizing Surveillance Decisions**\n\nI'm now prioritizing the combination of clinical assessment and duplex ultrasound, considering the need for both diagnostic accuracy and optimal follow-up frequency. While I weigh the merits of explicit ABI inclusion, option D's duplex schedule at 3, 6, 12 months, and 2 years, seems to offer the most effective stent surveillance.\n\n\n**Finalized Surveillance Strategy**\n\nGiven the provided options and my prior analysis, I'm now certain that the best strategy is Option D. It offers regular, strategic duplex ultrasound imaging, the gold standard for monitoring stent patency, at 3, 6, 12 months, and 2 years. Though ABI isn't explicitly mentioned, I'm confident that the combination of clinical examination and duplex ultrasound forms the most effective approach.\n\n\n**Choosing The Superior Option**\n\nI'm now prioritizing the combination of clinical assessment and duplex ultrasound, considering the need for accurate diagnosis and proper follow-up timing. Given my assessment of the provided choices, it seems that regular duplex scans, and the proper frequency, like Option D, offer a robust and reliable surveillance strategy. The early and frequent assessments will help catch any potential problems in the stent, particularly within the first two years after the procedure.\n\n\n",
            "reasoning_details": [
              {
                "type": "reasoning.text",
                "text": "**Assessing Surveillance Strategies**\n\nI'm currently reviewing various post-procedure surveillance options for SFA stenting. My focus is now on the established medical guidelines and best practices for follow-up care in these cases, to determine which program offers the most appropriate level of monitoring. I need to balance the need for early detection of complications against the invasiveness and cost of the surveillance methods.\n\n\n**Defining Optimal Surveillance Protocols**\n\nI'm now prioritizing the need for duplex ultrasound in any adequate surveillance program for SFA stenting. My evaluation hinges on comparing the options to standard guidelines for post-procedure care. While clinical assessment and ABI measurement are baseline requirements, the absence of duplex ultrasound, the primary imaging method to detect stent issues, is a critical shortcoming.\n\n\n**Comparing Surveillance Options**\n\nI'm now comparing and contrasting the proposed surveillance protocols in detail. I'm focusing on the necessity of duplex ultrasound, a crucial imaging modality. I'm noting the strengths and weaknesses of each option relative to standard guidelines. The frequency of imaging, specifically the presence and timing of duplex ultrasound, is the most crucial differentiator in evaluating the options.\n\n\n**Refining Protocol Recommendations**\n\nI'm now prioritizing the combination of clinical assessment, ABI measurement, and duplex ultrasound. Reviewing all options, I've concluded that regular duplex scans, even without explicit mention of ABI, are of greater value for SFA stenting surveillance. I'm focusing on the timing of these assessments, as frequent monitoring is crucial during the first year or two post-procedure. The optimal protocol balances clinical insights, physiological measurements, and, most critically, the utilization of duplex ultrasound imaging.\n\n\n**Determining the Ideal Choice**\n\nI'm now prioritizing the optimal combination of assessment modalities and their frequency for post-SFA stenting surveillance. Considering standard medical guidelines, I'm finding that options including duplex ultrasound, such as option B and D, are superior due to the imaging modality's diagnostic capabilities. Option D seems superior, providing extended surveillance to two years. While I prefer an option including both ABI and duplex, in a forced choice, duplex is more crucial for detecting stent-specific complications.\n\n\n**Choosing the Optimal Post-Procedure Plan**\n\nI'm now prioritizing the factors that inform my choice. Given the choices, and focusing on guidelines, I've concluded option D provides the most appropriate frequency for duplex ultrasound, essential for detecting issues in the stent. The 2-year surveillance period is also advantageous. While ABI is also important, and commonly done with duplex, duplex itself is more crucial for post-stenting imaging.\n\n\n**Choosing the Optimal Post-Procedure Plan**\n\nGiven the provided choices, I'm now comparing the merits of each post-operative plan. Option D, offering duplex ultrasound at 3, 6, 12 months, and 2 years, appears superior. It offers critical imaging, although not explicitly including ABI, the duplex ultrasound schedule aligns with standard surveillance guidelines, and the longer surveillance period is preferable.\n\n\n**Final Recommendation Refinement**\n\nConsidering all the presented choices and guidelines, I'm now leaning towards option D as the most effective surveillance strategy. It provides regular duplex ultrasound imaging, considered crucial for stent integrity assessment, and offers the best frequency. The 2-year surveillance aligns with the increased risk of late-stage complications, specifically relating to SFA stenting. While the absence of explicit ABI mention is a mild concern, the duplex schedule, combined with vascular assessment, makes it the superior choice.\n\n\n**Final Protocol Selection**\n\nI'm now focusing on SFA stenting. My choice has become clear: Option D is the most suitable, given my analysis and the guidelines. The critical factor is the inclusion of duplex ultrasound at frequent, strategic intervals, particularly during the first two years. Although ABI is vital, the duplex ultrasound schedule, coupled with routine vascular assessment, makes it the superior choice.\n\n\n**Finalizing Surveillance Decisions**\n\nI'm now prioritizing the combination of clinical assessment and duplex ultrasound, considering the need for both diagnostic accuracy and optimal follow-up frequency. While I weigh the merits of explicit ABI inclusion, option D's duplex schedule at 3, 6, 12 months, and 2 years, seems to offer the most effective stent surveillance.\n\n\n**Finalized Surveillance Strategy**\n\nGiven the provided options and my prior analysis, I'm now certain that the best strategy is Option D. It offers regular, strategic duplex ultrasound imaging, the gold standard for monitoring stent patency, at 3, 6, 12 months, and 2 years. Though ABI isn't explicitly mentioned, I'm confident that the combination of clinical examination and duplex ultrasound forms the most effective approach.\n\n\n**Choosing The Superior Option**\n\nI'm now prioritizing the combination of clinical assessment and duplex ultrasound, considering the need for accurate diagnosis and proper follow-up timing. Given my assessment of the provided choices, it seems that regular duplex scans, and the proper frequency, like Option D, offer a robust and reliable surveillance strategy. The early and frequent assessments will help catch any potential problems in the stent, particularly within the first two years after the procedure.\n\n\n",
                "format": "unknown",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "STOP"
        }
      ],
      "created": 1762216731,
      "model": "google/gemini-2.5-flash",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 2942,
        "prompt_tokens": 299,
        "total_tokens": 3241,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2888,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.007370253,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.97e-05,
          "upstream_inference_completions_cost": 0.007355
        }
      },
      "provider": "Google"
    }
  }
]